These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 37166997)
1. PP2A modulation overcomes multidrug resistance in chronic lymphocytic leukemia via mPTP-dependent apoptosis. Jayappa KD; Tran B; Gordon VL; Morris C; Saha S; Farrington CC; O'Connor CM; Zawacki KP; Isaac KM; Kester M; Bender TP; Williams ME; Portell CA; Weber MJ; Narla G J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37166997 [TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid resistance in chronic lymphocytic leukaemia is associated with a failure of upregulated Bim/Bcl-2 complexes to activate Bax and Bak. Melarangi T; Zhuang J; Lin K; Rockliffe N; Bosanquet AG; Oates M; Slupsky JR; Pettitt AR Cell Death Dis; 2012 Aug; 3(8):e372. PubMed ID: 22898870 [TBL] [Abstract][Full Text] [Related]
3. Extrinsic interactions in the microenvironment in vivo activate an antiapoptotic multidrug-resistant phenotype in CLL. Jayappa KD; Gordon VL; Morris CG; Wilson B; Shetty BD; Cios KJ; Arora PC; Isaac KM; Saha S; Bender TP; Williams ME; Portell CA; Weber MJ Blood Adv; 2021 Sep; 5(17):3497-3510. PubMed ID: 34432864 [TBL] [Abstract][Full Text] [Related]
4. DMFC (3,5-dimethyl- Xiang J; Wang Z; Liu Q; Li X; Sun J; Fung KP; Liu F Apoptosis; 2017 Mar; 22(3):381-392. PubMed ID: 27873035 [TBL] [Abstract][Full Text] [Related]
5. Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies. Chong SJF; Zhu F; Dashevsky O; Mizuno R; Lai JX; Hackett L; Ryan CE; Collins MC; Iorgulescu JB; Guièze R; Penailillo J; Carrasco R; Hwang YC; Muñoz DP; Bouhaddou M; Lim YC; Wu CJ; Allan JN; Furman RR; Goh BC; Pervaiz S; Coppé JP; Mitsiades CS; Davids MS J Clin Invest; 2023 Nov; 133(22):. PubMed ID: 37751299 [TBL] [Abstract][Full Text] [Related]
6. Crosstalk among Bcl-2 family members in B-CLL: seliciclib acts via the Mcl-1/Noxa axis and gradual exhaustion of Bcl-2 protection. Hallaert DY; Spijker R; Jak M; Derks IA; Alves NL; Wensveen FM; de Boer JP; de Jong D; Green SR; van Oers MH; Eldering E Cell Death Differ; 2007 Nov; 14(11):1958-67. PubMed ID: 17703234 [TBL] [Abstract][Full Text] [Related]
7. BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models. Vervloessem T; Sasi BK; Xerxa E; Karamanou S; Kale J; La Rovere RM; Chakraborty S; Sneyers F; Vogler M; Economou A; Laurenti L; Andrews DW; Efremov DG; Bultynck G Cell Death Dis; 2020 Sep; 11(9):769. PubMed ID: 32943617 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of p38 MAPK or immunoproteasome overcomes resistance of chronic lymphocytic leukemia cells to Bcl-2 antagonist venetoclax. Avsec D; Škrlj Miklavčič M; Burnik T; Kandušer M; Bizjak M; Podgornik H; Mlinarič-Raščan I Cell Death Dis; 2022 Oct; 13(10):860. PubMed ID: 36209148 [TBL] [Abstract][Full Text] [Related]
9. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses. Kitada S; Andersen J; Akar S; Zapata JM; Takayama S; Krajewski S; Wang HG; Zhang X; Bullrich F; Croce CM; Rai K; Hines J; Reed JC Blood; 1998 May; 91(9):3379-89. PubMed ID: 9558396 [TBL] [Abstract][Full Text] [Related]
11. Prosurvival Bcl-2 family members affect autophagy only indirectly, by inhibiting Bax and Bak. Lindqvist LM; Heinlein M; Huang DC; Vaux DL Proc Natl Acad Sci U S A; 2014 Jun; 111(23):8512-7. PubMed ID: 24912196 [TBL] [Abstract][Full Text] [Related]
12. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner. Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306 [TBL] [Abstract][Full Text] [Related]
13. BECN1 and BIM interactions with MCL-1 determine fludarabine resistance in leukemic B cells. Sharma A; Singh K; Mazumder S; Hill BT; Kalaycio M; Almasan A Cell Death Dis; 2013 May; 4(5):e628. PubMed ID: 23681223 [TBL] [Abstract][Full Text] [Related]
14. Spontaneous and drug-induced apoptosis is mediated by conformational changes of Bax and Bak in B-cell chronic lymphocytic leukemia. Bellosillo B; Villamor N; López-Guillermo A; Marcé S; Bosch F; Campo E; Montserrat E; Colomer D Blood; 2002 Sep; 100(5):1810-6. PubMed ID: 12176904 [TBL] [Abstract][Full Text] [Related]
15. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Rahmani M; Aust MM; Attkisson E; Williams DC; Ferreira-Gonzalez A; Grant S Cancer Res; 2013 Feb; 73(4):1340-51. PubMed ID: 23243017 [TBL] [Abstract][Full Text] [Related]
16. Apoptosis of B-cell chronic lymphocytic leukemia cells induced by a novel BH3 peptidomimetic. Ghiotto F; Fais F; Tenca C; Tomati V; Morabito F; Casciaro S; Mumot A; Zoppoli G; Ciccone E; Parodi S; Bruno S Cancer Biol Ther; 2009 Feb; 8(3):263-71. PubMed ID: 19164937 [TBL] [Abstract][Full Text] [Related]
17. Cotargeting BCL-2 and PI3K Induces BAX-Dependent Mitochondrial Apoptosis in AML Cells. Rahmani M; Nkwocha J; Hawkins E; Pei X; Parker RE; Kmieciak M; Leverson JD; Sampath D; Ferreira-Gonzalez A; Grant S Cancer Res; 2018 Jun; 78(11):3075-3086. PubMed ID: 29559471 [TBL] [Abstract][Full Text] [Related]